X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (383) 383
phlebitis - chemically induced (265) 265
female (247) 247
male (195) 195
adult (194) 194
middle aged (165) 165
aged (135) 135
thrombophlebitis - chemically induced (62) 62
phlebitis (53) 53
infusions, intravenous (50) 50
time factors (45) 45
contraceptives, oral - adverse effects (44) 44
injections, intravenous (44) 44
adolescent (43) 43
animals (39) 39
thrombophlebitis - drug therapy (35) 35
phlebitis - drug therapy (33) 33
antineoplastic agents - adverse effects (32) 32
phlebitis - prevention & control (32) 32
index medicus (31) 31
pregnancy (30) 30
oncology (29) 29
clinical trials as topic (28) 28
heparin - adverse effects (28) 28
pharmacology & pharmacy (28) 28
aged, 80 and over (27) 27
nausea - chemically induced (27) 27
drug evaluation (24) 24
phlebitis - epidemiology (24) 24
risk factors (24) 24
vomiting - chemically induced (24) 24
heparin - therapeutic use (22) 22
rabbits (22) 22
vinblastine - analogs & derivatives (22) 22
dose-response relationship, drug (21) 21
neoplasms - drug therapy (21) 21
phlebitis - etiology (21) 21
retrospective studies (21) 21
vinblastine - adverse effects (20) 20
breast neoplasms - drug therapy (19) 19
vinblastine - administration & dosage (19) 19
anticoagulants - therapeutic use (18) 18
hemorrhage - chemically induced (18) 18
infusions, parenteral (18) 18
pulmonary embolism - chemically induced (18) 18
thrombophlebitis (18) 18
antineoplastic agents - administration & dosage (17) 17
chemotherapy (17) 17
nursing (17) 17
prospective studies (17) 17
thrombocytopenia - chemically induced (17) 17
treatment outcome (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
diazepam - adverse effects (16) 16
drug administration schedule (16) 16
pain - chemically induced (16) 16
vinorelbine (16) 16
anticoagulants - adverse effects (15) 15
cephalothin - adverse effects (15) 15
double-blind method (15) 15
hydrogen-ion concentration (15) 15
leukopenia - chemically induced (15) 15
antineoplastic agents - therapeutic use (14) 14
antineoplastic agents, phytogenic - adverse effects (14) 14
incidence (14) 14
medicine, general & internal (14) 14
prevention (14) 14
thromboembolism - chemically induced (14) 14
cephalosporins - adverse effects (13) 13
amiodarone - adverse effects (12) 12
anti-bacterial agents - adverse effects (12) 12
antineoplastic agents, phytogenic - administration & dosage (12) 12
cancer (12) 12
child (12) 12
heparin - administration & dosage (12) 12
phlebitis - pathology (12) 12
streptokinase - therapeutic use (12) 12
thrombosis - chemically induced (12) 12
alopecia - chemically induced (11) 11
analysis (11) 11
follow-up studies (11) 11
infusions, intravenous - adverse effects (11) 11
vascular diseases - chemically induced (11) 11
administration, oral (10) 10
age factors (10) 10
anticoagulants - administration & dosage (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
bacterial infections - drug therapy (10) 10
cerebrovascular disorders - chemically induced (10) 10
child, preschool (10) 10
lung neoplasms - drug therapy (10) 10
medicine & public health (10) 10
myocardial infarction - drug therapy (10) 10
neoplasm metastasis (10) 10
phlebitis - diagnosis (10) 10
veins - drug effects (10) 10
antibiotics, antineoplastic - adverse effects (9) 9
blood coagulation tests (9) 9
drug therapy, combination (9) 9
fever - chemically induced (9) 9
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (269) 269
German (84) 84
French (31) 31
Japanese (10) 10
Italian (6) 6
Chinese (5) 5
Russian (4) 4
Spanish (4) 4
Polish (2) 2
Danish (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Supportive care in cancer, ISSN 1433-7339, 2014, Volume 22, Issue 5, pp. 1313 - 1317
...ORIGINAL ARTICLE Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy A. D. Leal & K. C. Kadakia & S. Looker & C... 
Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Adverse event | Oncology | Fosaprepitant | Nursing Management/Nursing Research | Chemotherapy-induced nausea and vomiting | Vein toxicity | CHEMOTHERAPY-INDUCED NAUSEA | ONCOLOGY | TOLERABILITY | HEALTH CARE SCIENCES & SERVICES | APREPITANT | PREVENTION | REHABILITATION | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nausea - chemically induced | Phlebitis - chemically induced | Humans | Middle Aged | Antiemetics - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Adult | Antiemetics - adverse effects | Female | Retrospective Studies | Nausea - drug therapy | Morpholines - adverse effects | Morpholines - therapeutic use | Doxorubicin - administration & dosage | Morpholines - administration & dosage | Vomiting - drug therapy | Breast Neoplasms - drug therapy | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Infusions, Intravenous | Doxorubicin - adverse effects | Complications and side effects | Cancer patients | Care and treatment | Chemotherapy | Analysis | Medical records | Nausea | Cancer | Side effects | Injections | Vomiting | Vein & artery diseases | Breast cancer | Preventive medicine | chemotherapy induced nausea and vomiting | adverse event | fosaprepitant | vein toxicity
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 1/2015, Volume 23, Issue 1, pp. 55 - 59
Fosaprepitant is an antiemetic used for chemotherapy-induced nausea and vomiting... 
Highly emetogenic chemotherapy | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Neurokinin-1 receptor antagonist | Oncology | Fosaprepitant | Phlebitis | Nursing Management/Nursing Research | INDUCED NAUSEA | EFFICACY | SAFETY | NEUROKININ-1 RECEPTOR ANTAGONISTS | PREVENTION | APREPITANT | SINGLE-DOSE FOSAPREPITANT | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | REHABILITATION | UPDATE | Anthracyclines - adverse effects | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Nausea - chemically induced | Phlebitis - chemically induced | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Adult | Antiemetics - adverse effects | Female | Retrospective Studies | Nausea - drug therapy | Vomiting - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Doxorubicin - administration & dosage | Vomiting - drug therapy | Neoplasms - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Aged | Anthracyclines - therapeutic use | Infusions, Intravenous | Doxorubicin - adverse effects | Cancer patients | Anthracyclines | Cyclophosphamide | Chemotherapy | Gastrointestinal agents | Analysis | Cancer | Side effects | Nausea | Preventive medicine | Vomiting | Toxicity | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2018, Volume 2018, Issue 7, p. CD008462
Background Intermittent locking of central venous catheters (CVCs) is undertaken to help maintain their patency. There are systematic variations in care: some... 
Thrombocytopenia | Kidney disease | Anticoagulants | Sodium Chloride | Central Venous Catheters | End‐stage kidney disease | Cannulation phlebitis | Medical prevention methods | Access | Catheterization, Central Venous | Thrombophlebitis | Haemodialysis | Hemorrhage | Catheters | Prevention | Catheter Obstruction | Heparin | Heart & circulation | IV fluids | Medicine General & Introductory Medical Sciences | Catheter‐Related Infections | Therapeutic Irrigation | Sodium Chloride [administration & dosage] | DOUBLE-LUMEN CATHETER | LOW-DOSE HEPARIN | Humans | TRISODIUM CITRATE 30-PERCENT | TUNNELED HEMODIALYSIS CATHETERS | NORMAL SALINE | RANDOMIZED CONTROLLED-TRIAL | Anticoagulants [administration & dosage] | INTERNAL JUGULAR-VEIN | Catheter Obstruction [statistics & numerical data] | Heparin [administration & dosage] | MEDICINE, GENERAL & INTERNAL | Therapeutic Irrigation [methods] | MOLECULAR-WEIGHT HEPARIN | Adult | CRITICALLY-ILL PATIENTS | BLOOD-STREAM INFECTIONS | Thrombocytopenia - epidemiology | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Heparin - administration & dosage | Sodium Chloride - administration & dosage | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Heparin - adverse effects | Therapeutic Irrigation - methods | Catheter Obstruction - statistics & numerical data | Hemorrhage - chemically induced | Catheter-Related Infections - epidemiology
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 7/2012, Volume 20, Issue 7, pp. 1549 - 1553
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 26, pp. 2457 - 2466
Journal Article
BMC infectious diseases, ISSN 1471-2334, 2019, Volume 19, Issue 1, pp. 558 - 6
Journal Article
The journal of vascular access, ISSN 1129-7298, 11/2019, Volume 20, Issue 6, pp. 786 - 787
... Risk factors for amiodarone-induced phlebitis (AIP) are many and include peripheral infusion, concentrations exceeding 2 mg/mL,2,3 higher dose of amiodarone... 
Phlebitis - chemically induced | Humans | Middle Aged | Risk Factors | Child, Preschool | Infant | Male | Phlebitis - diagnostic imaging | Amiodarone - administration & dosage | Incidence | Phlebitis - prevention & control | Amiodarone - adverse effects | Female | Aged | Retrospective Studies | Infusions, Intravenous | Phlebitis - epidemiology | Infant, Newborn
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2018, Volume 2018, Issue 2, p. CD004982
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1676 - 1684
Journal Article
Journal Article